Results 11 to 20 of about 107,589 (249)

Atypical presentation of autoimmune hepatitis–primary sclerosing cholangitis overlap syndrome associated with hypereosinophilia: a case report and review of the literature

open access: yesJournal of Medical Case Reports, 2021
Background Autoimmune hepatitis–primary sclerosing cholangitis overlap syndrome is a form of autoimmune hepatitis with cholestatic features and is characterized by negative anti-mitochondrial antibody and cholangiographic changes on magnetic resonance ...
Behzad Hatami   +2 more
doaj   +1 more source

Anti-ribosomal P (anti-P) antibodies in patients with autoimmune hepatitis

open access: yesEinstein (São Paulo), 2023
Objective Published studies have shown associations between anti-ribosomal P (anti-P) antibody and systemic lupus erythematosus with hepatic manifestations. This has been reported also in autoimmune hepatitis.
Clarisse de Almeida Gallo   +6 more
doaj   +1 more source

An Outbreak Presents An Opportunity to Learn About A Rare Phenotype: Autoimmune Hepatitis After Acute Hepatitis A

open access: yesAnnals of Hepatology, 2020
There are rare instances where patients with acute hepatitis A virus infection subsequently developed autoimmune hepatitis. The diagnosis of autoimmune hepatitis in this setting is challenging. Furthermore, information on treatment with steroids or other
Vijay S.-Are   +5 more
doaj   +1 more source

Case Report: Viral Pneumonia Could Prompt the Advancement of Immune-Mediated Liver Disease

open access: yesFrontiers in Medicine, 2021
Background: The impact of the influenza A (H1N1) and SARS-CoV-2 virus on the development of autoimmune hepatitis has not been described previously.Methods: In this case series, we evaluated the dynamic changes in liver function of three patients with ...
Qian Li   +9 more
doaj   +1 more source

New treatments/targets for primary biliary cholangitis

open access: yesJHEP Reports, 2019
Summary: Primary biliary cholangitis (PBC) is an autoimmune, cholestatic, chronic liver disease that ultimately progresses towards cirrhosis and liver failure if untreated.
Christophe Corpechot   +2 more
doaj   +1 more source

Autoimmune hepatitis

open access: yesJournal of Hepatology, 2000
Autoimmune hepatitis (AIH) is a rare disease, characterized by female predominance, hypergammaglobulinemia, autoantibodies, association with HLA DR3 and HLA DR4 and a good response to immunosuppression. Different subtypes of AIH may be distinguished, based on differences in the autoantibody patterns.
P, Obermayer-Straub   +2 more
  +7 more sources

Estimation of Thyroid Gland and Pancreatic Functioning in Patients with Chronic Hepatitis B and C Combined with Autoimmune Thyroiditis and without it

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2012
Chronic viral hepatitis is one of the most urgent problems of the healthcare. Viral hepatitis is not restricted with liver damage; they are like systemic disease proceeding with obligate development of extrahepatic manifestations.
Kh.T. Rustamova   +2 more
doaj   +1 more source

Occurrence of autoimmune chronic hepatitis in siblings [PDF]

open access: yesVojnosanitetski Pregled, 2005
Background. Autoimmune hepatitis is a chronic inflammatory disease of the liver of unknown etiology, characterized by the loss of tolerance against hepatic tissue, leading to the destruction of hepatic parenchyma.
Nožić Darko   +2 more
doaj   +1 more source

NAFLD‐related hepatocellular carcinoma: The growing challenge

open access: yesHepatology, EarlyView., 2022
Risk and protective factors for NAFLD‐related hepatocellular carcinoma Abstract Hepatocellular carcinoma (HCC) is a common cause of cancer‐related mortality and morbidity worldwide. With the obesity pandemic, NAFLD‐related HCC is contributing to the burden of disease exponentially.
Pir Ahmad Shah   +2 more
wiley   +1 more source

Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma

open access: yesHepatology, EarlyView., 2022
Steatotic HCC can be diagnosed by MRI and forms a pro‐tumor immune microenvironment with high expression of PD‐L1, M2 polarization of macrophages and activation of CAFs, which may be a good target for combined immunotherapy. Abstract Background and Aims Immunotherapy has become the standard‐of‐care treatment for hepatocellular carcinoma (HCC), but its ...
Hiroki Murai   +29 more
wiley   +1 more source

Home - About - Disclaimer - Privacy